We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

Farmers may one day be producing pharmaceutical products from their crops if a research programme made public yesterday is successful. The Pharma-Planta project aims to develop genetically modified (GM) plants capable of producing drugs and vaccines for diseases such as HIV/AIDS, malaria and rabies.

The European Union has invested US$14.8 million in the programme, which is being led by academics — rather than the biotechnology industry — from 39 laboratories in 11 European countries. The project's scientific coordinator estimates that plant-derived drugs and vaccines could cost ten to 100 times less than those produced conventionally.

Friends Of The Earth, a UK environmental group that lobbies against genetically modified crops, approves of the project's aims but says its research could have widespread negative impacts.

Link to the full BBC Online news story